Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BDB018 |
Trade Name | |
Synonyms | BDB 018|BDB-018 |
Drug Descriptions |
BDB018 acts an an agonist of TLR7 and TLR8, potentially resulting in activation of the anti-tumor immune response and tumor cell lysis (NCI Drug Dictionary). |
DrugClasses | TLR7 Agonist 12 TLR8 Agonist 9 |
CAS Registry Number | NA |
NCIT ID | C180587 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BDB018 | BDB018 | 0 | 1 |
BDB018 + Pembrolizumab | BDB018 Pembrolizumab | 0 | 1 |